Introduction
Pathogenesis of obesity is multifactorial and involves both genetics and environmental factors [1] . Many genes are involved in regulatory pathways for weight gain and obesity. These genes include leptin, leptin receptors, melanocortin receptor 4, mitochondrial uncoupling proteins, peroxisome proliferator-activated receptor-gamma (PPARγ), neuropeptide Y, and ghrelin as well as genes in signaling pathways [2] . PPARs are ligand-dependent transcription factors that are involved in the genetic regulation of mammalian metabolism [3] . PPARγ plays a pivotal role in the regulation of adipocyte differentiation, energy storage, insulin sensitivity, and lipid metabolism [3] . A point mutation found on the B exon of the NH2-terminal of PPARγ, substitution of proline with alanine at position 12 (PPARγ Pro12Ala SNP) (rs1801282), causes a moderate decrease in its transcription activity and adipogenic potential [4, 5] . Several meta-analyses and genomewide association studies have confirmed the relationship between the Pro variant and the risk of type 2 diabetes [6] . Recently, new opportunities for human genome research have appeared; many studies have been conducted in this area, but evidence for obesity is limited and inconsistent [7, 8] . Some studies have shown an association between the aforementioned single nucleotide polymorphism (SNP) and obesity [9, 10] , but these have not been confirmed by other studies [11, 12] . Some systematic studies were conducted in regard to the association of this particular SNP and obesity [13] [14] [15] . However, the participants in most of the studies included were diabetic patients. Considering the fact that a significantly higher rate of overweight and obesity was found in persons with type 2 diabetes as compared to the general population, and that nutritional intervention and oral hypoglycemic agents in diabetic patients might affect their body weight [16] , this study also suggested a potential interaction between this SNP and dietary intervention on body weight [17, 18] ; thus, it may limit the generalizability of previous findings to healthy individuals. Therefore, the present systematic review and meta-analyses aim to investigate the association between obesity and Pro12Ala polymorphism of PPARγ gene in healthy adults.
Methods

Search Strategy
This study was conducted with a prospective protocol, which included a predefined research question, search strategy, study eligibility criteria, and methods of data extraction and statistical analysis. We followed preferred reporting items for systematic reviews and meta-analyses guidelines for the reporting of this study [19] .
We performed a systematic search for relevant studies by the 3 major databases PubMed, Embase, and Scopus in English up to April 2014, which involved humans. The key terms and medical subject heading [MeSH] were used in different combinations of the following search criteria: 'obesity' [MeSH] , 'obese', 'overweight', 'body weight', 'body fat', 'body mass index', 'BMI', 'skinfold thickness', 'adiposity', 'body composition', 'peroxisome proliferator-activated receptor gamma', 'PPARgamma' [MeSH] , 'peroxisome proliferator-activated receptor-gamma 2', 'PPARgamma2', 'PPARG', 'PPARG2', 'peroxisome proliferators-activated receptor', 'PPAR', 'PPAR 2', 'Pro12Ala', 'P12A', 'Ala12', 'Pro12', 'Ala carrier', and 'non-Ala carrier'. Furthermore, we reviewed reference lists of the obtained articles to search for additional studies.
Selection Criteria
The predetermined inclusion criteria of the original studies were (1) studies that included the mean BMI values for each genotype of the Pro12Ala polymorphism of PPARγ gene (2) cohort studies, clinical trials, population case-control studies (investigating healthy participants with no matching between control and cases) or crosssectional studies. If the data were duplicated in more than 1 study, the most recent and comprehensive study was included in the metaanalysis. Exclusion criteria included (1) studies that do not meet the inclusion criteria, (2) participants less than 18 years of age, (3) unhealthy subjects with cancer, diabetes, cardiovascular disease, polycystic ovary syndrome and other endocrine dysfunctions.
Data Extraction
All relevant articles were reviewed and duplicates deleted. Relevant articles (titles and abstracts) were screened by the authors (A.M. and M.A.) independently to select potentially articles for the review. The studies reporting our data of interest were screened for eligibility. For each included study, the following information was extracted: first author name, year of publication, mean and SD or SE of BMI by genotypes, country of study, racial background of the subjects, study design, source of the study population, gender, age, sample size, and confounding factors accounted for.
Statistical Analysis
The mean difference and SD of BMI in cohort, population casecontrol, cross-sectional studies, and the first data of clinical trials were considered. When SE or CI were reported, the values of SD were calculated. The frequencies of Ala/Ala homozygote in individuals are extremely rare. To ensure adequate statistical power, we included individuals with the Pro/Ala genotype along with individuals with the Ala/Ala genotype (as Ala + ) when comparing their data with individuals with the Pro/Pro (as Ala -). Moreover, both dominant and recessive models were performed for studies that mentioned BMI values for Ala/Ala genotype.
Between-study heterogeneity was evaluated by Cochran's Q statistical test and I 2 metric [20] , which describe the percentage of total variation in point estimates attributable to genuine variation rather than sampling error, and notable considered when I 2 was >50% [21] . A threshold of p < 0.1 was used to identify the presence of heterogeneity. Random-effects models were used to calculate the pooled mean difference of BMI level in response to genotype [22] . The weighted mean difference (WMD) was used as a measure of the relationship between Pro12Ala polymorphism of PPARγ gene and BMI. Potential sources of heterogeneity were identified in predefined subgroups including gender (male, female), ethnicity (Caucasian, Asian, and mixed populations, for example, African and Latin American), study design, and following the hypothesis that Ala carrier of this particular SNP may have a stronger effect on BMI in markedly obese persons, and in order to compare the results of the current study with those of the previous study [13] , we also stratified by BMI levels (<27, 27 ≤ , <35, and ≥ 35 kg/m 2 ). A cumulative meta-analysis was performed to show the consequence of adding studies on the effect size over time [23] . Publication bias was assessed by funnel plot and formal testing for asymmetric of funnel plot using Egger's test [24] . The funnel plot was considered to be asymmetrical if the intercept of Egger's regression deviation deviated from zero with p < 0.1. The meta-analysis was conducted using Stata software (version 12.0; StataCorp, College Station, Tex., USA). All the p values were 2-sided and the results were regarded as statistically significant if p < 0.05.
Results
Description of Studies
A total of 363 potentially relevant citations were retrieved by searching databases. Twelve articles were excluded because of duplication. Another 213 studies were excluded during the review because they were in vitro or review studies, studies which genotyped other PPARγ polymorphisms, and studies with other disease or disorders population. Therefore, full text of 138 eligible articles was evaluated. After careful review of the content, another 82 studies were excluded because of missing information, reporting on the same study participants, investigating children, and including participants with a variety of disease or disorders. Finally, a total of 56 articles fulfilled the eligibility criteria and were included in the meta-analyses. The flow diagram of the selection process for the meta-analysis is displayed in figure 1 .
Nine cohort studies [12, [25] [26] [27] [28] [29] [30] [31] [32] ] , 7 population casecontrol studies [33] [34] [35] [36] [37] [38] [39] , 31 cross-sectional studies [5, 7, 10, , and 9 interventional studies [8, [68] [69] [70] [71] [72] [73] [74] [75] were included in the meta-analysis of the association between PPARγ Pro12Ala polymorphism and obesity. The characteristics and results of the studies are summarized in table 1 . Seven population case-control studies [33] [34] [35] [36] [37] [38] [39] , and 1 cross-sectional study [10] provided their data in 2 datasets. Each dataset was treated as a separate comparison in the meta-analysis. Forty studies were on Caucasians [5, 8, 10, 12, 25-29, 32-39, 41-43, 45-48, 52-54, 57, 60-70] , 10 studies were on Asian [31, 40, 49, 50, 55, 56, 58, 59, 71, 72] and 6 studies were on mixed populations [7, 30, 37, [73] [74] [75] . Between 56 studies, 19 studies provided data on male [10, 12, 29, 33, 35, 37, 40, 42, 43, 47, 50, 57, 60-62, 65, 66, 69, 71] and 22 studies on female members [10, 12, 29, 32, 37, 41, 42, 50, 53-55, 59-62, 64, 66, 68, 69, 72-74] .
Pooled Analyses
Overall Studies A total of 39,647 participants were included in this meta-analysis. Of these participants, 31,988 of them had Pro/Pro genotype (80.68%) and 7,623 were carriers of the Ala allele (19.22%). We performed meta-analyses on total comparisons. The pooled analysis of whole studies on the association between WMD of BMI and PPARγ Pro12Ala polymorphism showed mild association of Ala carriers (Ala + ) with increased WMD of BMI than fig. 2 ). Further analyses were performed for gender, ethnicity, BMI status, and study design subgroups to investigate the source of heterogeneity ( table 2 ) . In subgroup analyses for study design, significant heterogeneity was found for cohort and cross-sectional studies (p for heterogeneity = 0.005 and <0.001, respectively), but not for interventional and population case-control studies ( table 2 ) fig. 5 ). All ethnicity subgroups were heterogeneous (heterogeneity test for Caucasian p < 0.001, I 2 = 58.7%, for Asian p = 0.03, I 2 = 50.8% and for mixed populations p < 0.001, I 2 = 76.6%). More investigation by BMI categories in Caucasians showed that in both 27 ≤ BMI <35 and BMI ≥ 35 subgroups, Ala + was associated with an increased WMD of BMI ( table 2 ) . 
Pooled Analyses of Studies in Dominant and
Discussion
This study suggested that the PPARγ Pro12Ala polymorphism was associated with the BMI level. The Ala allele of this particular SNP is associated with an increase of 0.29 units in BMI, and this association was seen in both genders. Moreover, in the meta-analysis of ethnic subgroups, the Ala allele of this particular SNP was associated with an increase of 0.18 units in BMI in Caucasians. However, this significant relationship was not observed in the Asians and mixed populations. This difference may be explained by the discrepancy in the body weight distribution and the lifestyles of the ethnic groups. Luan et al. [12] reported a gene-diet interaction with regard to PPARγ Pro12Ala polymorphism. They showed an inverse association between polyunsaturated to saturated fatty acids ratio with BMI and plasma insulin levels in Ala carriers [12] , and in subsequent studies, the relationship between this polymorphism and nutrient intakes on BMI or waist circumference was verified [17, 18, 27] . Thus, it might be possible that different dietary patterns between ethnic groups could modulate the relationship between BMI and this particular SNP. In the meta-analysis of BMI subgroups, Ala allele was associated with an increase of 0.96 units for BMI ≥ 35. Moreover, when meta-analysis was restricted to Caucasians, this association was observed in individuals with 27 ≤ BMI <35 and BMI ≥ 35.
In most studies, because of the low frequency of Ala/ Ala genotype, BMI values were presented in the combined form of Pro/Ala and Ala/Ala. Thus, this meta-analysis was performed under a dominant model, which was a comparison between Pro/Pro genotype and combined form of Pro/Ala and Ala/Ala. Moreover, both recessive and dominant models were performed for studies that mentioned BMI values for Ala/Ala genotype. The results presented a significant relationship only in the dominant model. Therefore, the Ala allele of this particular SNP was associated with an increase in BMI under a dominant model of inheritance.
Previous studies investigated the relationship between this particular SNP and BMI, where a majority of participants were unhealthy individuals [13] [14] [15] . In a separate subgroup meta-analyses of diabetic and nondiabetic individuals, it was reported that this SNP effect on BMI was not observed in the diabetic group [14] . This confirms the necessity of excluding non-healthy individuals for exploring the real association, which was considered in these pooled analyses. Thus, in the present meta-analyses, only healthy adult participants were included. In agreement with our data, previous metaanalyses reported an association between Ala allele and BMI value, especially in the BMI ≥ 27 subgroup [13] . However, in this study, a stronger association between Ala carriers and increase in BMI value was observed (an increase of 0.06 in the previous study verses an increase of 0.29 units in the present study). The possible explanations for this discrepancy may be due to the inclusion of more studies in our meta-analyses and due to the inclusion of only healthy participants. Yao et al. [15] pooled 25 studies that showed that Ala carriers were associated with the obesity risk in comparison with the non-carriers; however, they used the odds ratio for obesity from different levels of BMI ( ≥ 24, ≥ 30 and ≥ 95th percentile).
A plausible mechanism of the effect of this particular SNP is probably mediated by an increase in insulin sensitivity. This may be secondary to more efficient suppression of free fatty acids release from fat tissue, where PPARγ is expressed [76] . Stumvoll et al. [77] 116 that during the hyper-insulinaemic clamp, non-esterified fatty acids concentration was almost 50% lower in the Ala variant. More efficient suppression of lipolysis in this group could tilt the regulated balance between lipolysis and lipogenesis slightly toward lipogenesis and weight gain.
The results of this meta-analysis should be interpreted with the consideration of some limitations. First of all, we only included the studies published in English. Second, this meta-analysis showed significant inter-studies heterogeneities, which is a common problem in meta-analysis for genetic associations [78] . However, we performed subgroups analysis and showed that the study design is a main source of heterogeneity. In most of the subgroup analyses, heterogeneity remained, and this suggests that heterogeneity in our study could be due to other factors. Third, other SNPs and environmental factors involved in BMI value were not considered confounders because of lack of sufficient data. The major strengths are the large sample size and the absence of publication bias. We also conducted extensive sensitivity analyses excluding studies that did not meet specific criteria for study design.
In conclusion, our results suggest that the Ala allele of the PPARγ Pro12Ala polymorphism is associated with increased BMI under a dominant model of inheritance in both genders. In subgroup analyses, this relationship was seen only in the higher levels of BMI (BMI ≥ 35) and among Caucasians. Further studies considering gene-gene and gene-environment interaction are potentially recommended to elucidate these associations more clearly.
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